Complete Filing Data
enGene Therapeutics Inc. reported Stockholders Equity of $72.49 million for FY2023.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean enGene Therapeutics Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Income * | -$117.3M | -$55.1M | -$99.9M | -$24.5M |
| Other Nonoperating Income Expense | -$569.0K | -$113.0K | -$129.0K | -$662.0K |
| Operating Income Loss | -$123.2M | -$62.3M | -$26.1M | -$19.4M |
| General And Administrative Expense | $28.7M | $24.0M | $9.6M | $4.0M |
| Research And Development Expense | $94.5M | $38.3M | $16.5M | $15.5M |
| Operating Expenses | $123.2M | $62.3M | $26.1M | $19.4M |
| Nonoperating Income Expense | $5.9M | $7.1M | -$73.8M | -$5.0M |
| Income Tax Expense Benefit | $0.00 | -$19.0K | $17.0K | $22.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$117.3M | -$55.2M | -$99.9M | -$24.4M |
| Non Cash Interest Expense | $854.0K | $806.0K | $778.0K | $644.0K |
| Interest Expense Nonoperating | $3.0M | $2.8M | $5.0M | |
| Comprehensive Income Net Of Tax | -$116.8M | -$54.7M | -$99.9M | -$23.3M |
| Net Income Loss Available To Common Stockholders Diluted | -$55.1M | -$104.7M | -$29.0M | |
| Net Income Loss Available To Common Stockholders Basic | -$55.1M | -$104.7M | -$29.0M | |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $531.0K | -$403.0K | ||
| Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | $531.0K | $403.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$29.8M | -$29.0M | -$25.8M | -$24.6M | -$14.1M | -$15.0M | -$10.7M | -$4.7M | -$5.3M | -$7.4M |
| Other Nonoperating Income Expense | -$87.0K | -$280.0K | -$205.0K | $37.0K | -$47.0K | $91.0K | -$64.0K | -$439.0K | $199.0K | -$285.0K |
| Operating Income Loss | -$31.2M | -$29.9M | -$27.1M | -$26.6M | -$16.8M | -$17.3M | -$10.8M | -$6.2M | -$4.7M | -$4.6M |
| General And Administrative Expense | $8.9M | $7.4M | $6.9M | $6.6M | $5.2M | $7.5M | $5.1M | $2.3M | $1.5M | $962.0K |
| Research And Development Expense | $22.3M | $22.6M | $20.2M | $20.0M | $11.5M | $9.9M | $5.6M | $3.9M | $3.2M | $3.7M |
| Operating Expenses | $31.2M | $29.9M | $27.1M | $26.6M | $16.8M | $17.3M | $10.8M | $6.2M | $4.7M | $4.6M |
| Nonoperating Income Expense | $1.4M | $1.2M | $1.5M | $2.0M | $2.6M | $2.3M | $32.0K | $1.5M | -$545.0K | -$2.8M |
| Income Tax Expense Benefit | $0.00 | $239.0K | $240.0K | $18.0K | -$29.0K | $21.0K | -$30.0K | $0.00 | $0.00 | $0.00 |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$29.8M | -$28.8M | -$25.6M | -$24.6M | -$14.2M | -$15.0M | -$10.7M | -$4.7M | -$5.3M | -$7.4M |
| Non Cash Interest Expense | $183.0K | $215.0K | $164.0K | $1.2M | ||||||
| Interest Expense Nonoperating | $732.0K | $758.0K | $734.0K | $752.0K | $751.0K | $728.0K | $563.0K | $1.4M | ||
| Comprehensive Income Net Of Tax | -$29.7M | -$29.2M | -$25.5M | -$24.5M | -$14.1M | -$15.0M | -$10.7M | |||
| Net Income Loss Available To Common Stockholders Diluted | -$14.1M | -$15.0M | -$10.7M | -$6.0M | -$6.5M | -$8.7M | ||||
| Net Income Loss Available To Common Stockholders Basic | -$14.1M | -$15.0M | -$10.7M | -$6.0M | -$6.5M | -$8.7M | ||||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $46.0K | -$240.0K | $306.0K | $144.0K | ||||||
| Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | $46.0K | -$240.0K | $306.0K | $144.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Stockholders Equity | $72.5M | -$76.6M | -$53.4M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $81.5M | $20.4M | |||
| Retained Earnings Accumulated Deficit | -$254.7M | -$199.6M | -$99.7M | ||
| Liabilities Current | $14.7M | $5.3M | $5.1M | ||
| Liabilities And Stockholders Equity | $311.2M | $87.0M | $23.9M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$122.9M | $91.5M | $61.1M | $9.4M | |
| Assets | $311.2M | $87.0M | $23.9M | ||
| Restricted Investments | $72.0K | $76.0K | $74.0K | ||
| Property Plant And Equipment Net | $1.2M | $589.0K | $387.0K | ||
| Prepaid Expense And Other Assets Current | $8.6M | $1.5M | $739.0K | ||
| Other Assets Noncurrent | $1.4M | $930.0K | $939.0K | ||
| Long Term Notes Payable | $22.5M | $9.2M | $9.6M | ||
| Liabilities | $38.6M | $14.5M | $47.4M | ||
| Investment Tax Credits Receivable | $332.0K | $2.3M | $1.3M | ||
| Common Stock Value | $509.8M | $259.4M | $16.4M | ||
| Cash And Cash Equivalents At Carrying Value | $173.0M | $81.5M | $20.4M | ||
| Assets Current | $247.4M | $85.4M | $22.6M | ||
| Additional Paid In Capital Common Stock | $19.0M | $13.7M | $7.7M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$1.4M | -$1.0M | -$1.0M | ||
| Accrued Liabilities And Other Liabilities | $12.1M | $3.5M | $3.1M | ||
| Accounts Payable Current | $1.4M | $1.2M | $723.0K | ||
| Notes Payable Current | $699.0K | $562.0K | $1.3M | ||
| Common Stock No Par Value | $0.00 | ||||
| Non Cash Lease Expenses | -$378.0K | -$163.0K | $5.0K | ||
| Operating Lease Right Of Use Asset | $1.7M | ||||
| Operating Lease Liability Noncurrent | $1.4M | ||||
| Operating Lease Liability Current | $423.0K | ||||
| Gains Losses On Extinguishment Of Debt | $0.00 | -$366.0K | -$3.1M | ||
| Marketable Securities Noncurrent | $59.5M | ||||
| Marketable Securities Current | $65.3M | ||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $6.4M | $1.9M | |||
| Redeemable Preferred Stock Dividends | $4.8M | $4.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $281.5M | $167.7M | $200.7M | $227.3M | $250.0M | $272.6M | $230.3M | $243.0M | $62.4M | -$93.9M | -$89.2M | -$84.0M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $36.6M | $50.2M | $32.6M | $57.5M | $62.3M | $173.0M | $257.7M | $264.8M | $85.6M | $37.6M | $17.5M | $14.2M | |
| Retained Earnings Accumulated Deficit | -$401.8M | -$372.0M | -$334.2M | -$305.2M | -$279.3M | -$239.4M | -$225.3M | -$210.3M | |||||
| Liabilities Current | $24.6M | $32.0M | $20.4M | $18.0M | $13.0M | $13.5M | $6.3M | $6.9M | |||||
| Liabilities And Stockholders Equity | $337.1M | $221.5M | $245.6M | $266.7M | $285.9M | $266.9M | $273.5M | $93.4M | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$13.5M | -$110.7M | $4.1M | -$6.2M | |||||||||
| Assets | $337.1M | $221.5M | $245.6M | $266.7M | $285.9M | $266.9M | $273.5M | $93.4M | |||||
| Restricted Investments | $74.0K | $79.0K | $72.0K | $72.0K | $75.0K | $75.0K | $75.0K | $79.0K | |||||
| Property Plant And Equipment Net | $2.4M | $2.5M | $1.9M | $1.6M | $1.4M | $1.0M | $1.1M | $993.0K | |||||
| Prepaid Expense And Other Assets Current | $12.0M | $6.6M | $8.6M | $10.0M | $8.0M | $4.7M | $3.5M | $2.7M | |||||
| Other Assets Noncurrent | $1.4M | $1.4M | $1.4M | $1.4M | $1.6M | $1.4M | $975.0K | $974.0K | |||||
| Long Term Notes Payable | $24.7M | $15.3M | $17.7M | $20.0M | $21.7M | $21.6M | $22.7M | $22.5M | |||||
| Liabilities | $55.6M | $53.8M | $44.9M | $39.4M | $36.0M | $36.6M | $30.6M | $31.0M | |||||
| Investment Tax Credits Receivable | $1.2M | $927.0K | $709.0K | $533.0K | $430.0K | $241.0K | $1.2M | $1.1M | |||||
| Common Stock Value | $632.0M | $513.3M | $510.2M | $510.1M | $509.8M | $453.5M | $453.4M | $259.4M | |||||
| Cash And Cash Equivalents At Carrying Value | $36.6M | $50.2M | $32.6M | $57.5M | $62.3M | $257.7M | $264.8M | $85.6M | |||||
| Assets Current | $289.2M | $201.4M | $211.3M | $228.0M | $222.3M | $262.7M | $269.6M | $89.6M | |||||
| Additional Paid In Capital Common Stock | $52.2M | $27.3M | $25.9M | $23.3M | $20.8M | $17.3M | $15.9M | $14.3M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$842.0K | -$888.0K | -$1.2M | -$969.0K | -$1.3M | -$1.0M | -$1.0M | -$1.0M | |||||
| Accrued Liabilities And Other Liabilities | $19.7M | $15.3M | $11.1M | $12.4M | $8.2M | $8.8M | $5.7M | $5.2M | |||||
| Accounts Payable Current | $2.4M | $6.7M | $2.4M | $1.6M | $2.6M | $2.9M | $211.0K | $1.3M | |||||
| Notes Payable Current | $188.0K | $8.0M | $5.4M | $3.6M | $1.7M | $1.3M | |||||||
| Common Stock No Par Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Non Cash Lease Expenses | -$246.0K | -$50.0K | -$27.0K | ||||||||||
| Operating Lease Right Of Use Asset | $7.5M | $7.7M | $8.0M | $1.6M | $1.7M | $1.8M | $1.8M | $1.9M | |||||
| Operating Lease Liability Noncurrent | $6.2M | $6.5M | $6.7M | $1.3M | $1.3M | $1.5M | $1.5M | $1.6M | |||||
| Operating Lease Liability Current | $2.3M | $2.0M | $1.5M | $431.0K | $416.0K | $422.0K | $421.0K | $393.0K | |||||
| Gains Losses On Extinguishment Of Debt | -$488.0K | $0.00 | -$366.0K | ||||||||||
| Marketable Securities Noncurrent | $36.6M | $8.5M | $23.0M | $34.1M | $59.0M | ||||||||
| Marketable Securities Current | $239.3M | $143.6M | $169.3M | $159.8M | $151.5M | ||||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $1.9M | ||||||||||||
| Redeemable Preferred Stock Dividends | $1.3M | $1.2M | $1.2M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $9.6M | $5.3M | $3.5M | $116.0K |
| Net Cash Provided By Used In Operating Activities | -$99.2M | -$48.3M | -$24.7M | -$17.6M |
| Net Cash Provided By Used In Investing Activities | -$25.1M | -$126.0M | -$318.0K | -$153.0K |
| Net Cash Provided By Used In Financing Activities | $1.5M | $265.7M | $86.1M | $28.0M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.0K | $1.0K | $1.0K | -$805.0K |
| Share Based Compensation | $9.6M | $5.3M | $3.5M | $116.0K |
| Payments To Acquire Property Plant And Equipment | $1.5M | $925.0K | $318.0K | $153.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$2.0M | $7.6M | $751.0K | $113.0K |
| Increase Decrease In Investment Tax Credit Receivable | $595.0K | -$2.0M | $1.0M | -$143.0K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $3.1M | $5.2M | $868.0K | $2.3M |
| Increase Decrease In Accounts Payable | $4.9M | $474.0K | $373.0K | -$197.0K |
| Proceeds From Stock Options Exercised | $2.2M | $113.0K | $44.0K | $12.0K |
| Increase Decrease In Operating Lease Liability | $274.0K | -$49.0K | ||
| Proceeds From Issuance Of Debt | $22.5M | $11.0M | ||
| Payments Of Debt Issuance Costs | $585.0K | $391.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $2.8M | $2.6M | $2.7M | $1.8M | $1.5M | $1.9M | $291.0K | $37.0K | $39.0K | $20.0K |
| Net Cash Provided By Used In Operating Activities | -$28.9M | -$25.7M | -$7.4M | -$6.2M | ||||||
| Net Cash Provided By Used In Investing Activities | -$126.3M | -$85.0M | -$506.0K | -$13.0K | ||||||
| Net Cash Provided By Used In Financing Activities | $141.7M | $1.0K | $12.0M | -$10.0K | ||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.0K | $1.0K | $1.0K | $1.0K | ||||||
| Share Based Compensation | $2.8M | $1.8M | $291.0K | $20.0K | ||||||
| Payments To Acquire Property Plant And Equipment | $153.0K | $299.0K | $506.0K | $13.0K | ||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $2.4M | -$419.0K | $1.3M | $60.0K | ||||||
| Increase Decrease In Investment Tax Credit Receivable | $271.0K | $98.0K | -$1.2M | $388.0K | ||||||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $4.4M | -$3.9M | $2.2M | -$1.8M | ||||||
| Increase Decrease In Accounts Payable | -$4.3M | $1.1M | $217.0K | $827.0K | ||||||
| Proceeds From Stock Options Exercised | $277.0K | $1.0K | ||||||||
| Increase Decrease In Operating Lease Liability | $39.0K | -$168.0K | $37.0K | |||||||
| Proceeds From Issuance Of Debt | $25.0M | $22.5M | ||||||||
| Payments Of Debt Issuance Costs | $615.0K | $442.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 51.1M | 37.8M | 692.6K | 655.2K |
| Weighted Average Number Of Diluted Shares Outstanding | 51.1M | 37.8M | 692.6K | 655.2K |
| Earnings Per Share Diluted | $2.29 | $1.46 | $151.22 | $44.30 |
| Earnings Per Share Basic | $2.29 | $1.46 | $151.22 | $44.30 |
| Common Stock Shares Outstanding | 51.0M | 23.2M | 665.8K | |
| Common Stock Shares Issued | 51.0M | 23.2M | 665.8K | |
| Preferred Stock Shares Outstanding | 0.00 | |||
| Preferred Stock Shares Issued | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 67.3M | 51.1M | 51.0M | 51.0M | 44.2M | 39.4M | 23.2M | 701.3K | 694.5K | 651.1K | ||
| Weighted Average Number Of Diluted Shares Outstanding | 67.3M | 51.1M | 51.0M | 51.0M | 44.2M | 39.4M | 23.2M | 701.3K | 694.5K | 651.1K | ||
| Earnings Per Share Diluted | $0.44 | $0.57 | $0.51 | $0.48 | $0.32 | $0.38 | $0.46 | $8.55 | $9.30 | $13.29 | ||
| Earnings Per Share Basic | $0.44 | $0.57 | $0.51 | $0.48 | $0.32 | $0.38 | $0.46 | $8.55 | $9.30 | $13.29 | ||
| Common Stock Shares Outstanding | 67.0M | 52.0M | 51.1M | 51.1M | 51.0M | 44.2M | 44.2M | 23.2M | ||||
| Common Stock Shares Issued | 67.0M | 52.0M | 51.1M | 51.1M | 51.0M | 44.2M | 44.2M | 23.2M | ||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Investment Income Interest | $9.4M | $10.4M | $1.1M | $129.0K |
| Stock Issued During Period Value Stock Options Exercised | $2.2M | $113.0K | $44.0K | $7.0K |
| Depreciation | $509.0K | $323.0K | $175.0K | $238.0K |
| Interest Paid Net | $2.3M | $1.9M | $1.4M | $615.0K |
| Foreign Currency Transaction Gain Loss Unrealized | -$3.0K | $6.0K | -$489.0K | |
| Repayments Of Term Loan Principal | $699.0K | $9.4M | $1.6M | |
| Stock Issued During Period Shares Stock Options Exercised | 1.0M | 116.8K | 84.1K | |
| Payment Of Reverse Recapitalization And Pipe Financing Costs | $613.0K | $10.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Investment Income Interest | $2.7M | $2.2M | $2.5M | $2.7M | $3.4M | $3.0M | $1.0M | $394.0K | $149.0K | $167.0K |
| Stock Issued During Period Value Stock Options Exercised | $277.0K | $31.0K | $200.0K | $1.0K | $51.0K | $51.0K | $17.0K | |||
| Depreciation | $189.0K | $102.0K | $80.0K | $46.0K | ||||||
| Interest Paid Net | $544.0K | $532.0K | $283.0K | |||||||
| Foreign Currency Transaction Gain Loss Unrealized | -$69.0K | -$127.0K | -$66.0K | $82.0K | ||||||
| Repayments Of Term Loan Principal | $23.1M | $9.4M | ||||||||
| Stock Issued During Period Shares Stock Options Exercised | 117.9K | 884.00 | 0.00 | |||||||
| Payment Of Reverse Recapitalization And Pipe Financing Costs | $613.0K |
Most recent annual filing with the SEC: December 22, 2025
Data sourced from SEC EDGAR public filings as of August 8, 2026.